These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28577207)

  • 1. Vitiligo: An Update on Pathophysiology and Treatment Options.
    Speeckaert R; van Geel N
    Am J Clin Dermatol; 2017 Dec; 18(6):733-744. PubMed ID: 28577207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitiligo Pathogenesis and Emerging Treatments.
    Rashighi M; Harris JE
    Dermatol Clin; 2017 Apr; 35(2):257-265. PubMed ID: 28317534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging Molecular Mechanism and Clinical Practice in Vitiligo Treatment: An Updated Review.
    Ju HJ; Bae JM
    Dermatology; 2024; 240(3):474-486. PubMed ID: 38417409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of natural health product treatment for vitiligo.
    Szczurko O; Boon HS
    BMC Dermatol; 2008 May; 8():2. PubMed ID: 18498646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation.
    An L; Kim D; Donahue LR; Mejooli MA; Eom CY; Nishimura N; White AC
    Nat Commun; 2024 Jan; 15(1):796. PubMed ID: 38280858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the refractory vitiligo patient: current therapeutic strategies and future options.
    Wang X; Wu W; Chen J; Li C; Li S
    Front Immunol; 2023; 14():1294919. PubMed ID: 38239366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Combined Phototherapy and Melanocyte Transplantation on Indicators of Vitiligo Activity.
    Wang J; Luo H; Zhao X; Wang C; Yang L
    Dermatol Surg; 2024 Jul; ():. PubMed ID: 38984521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the impact of diet and nutrition on vitiligo: A systematic review of dietary factors and nutritional interventions.
    Hadi Z; Kaur R; Parekh Z; Khanna S; Khalil ABB; Abbasi HQ; Ashfaque F; Shah D; Patel VJ; Hasibuzzaman MA
    J Cosmet Dermatol; 2024 Jul; 23(7):2320-2327. PubMed ID: 38465786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic Reticulum Dysfunction: An Emerging Mechanism of Vitiligo Pathogenesis.
    Xie Y; Wu N; Tang S; Zhou Z; Chen J; Li J; Wu F; Xu M; Xu X; Liu Y; Ma X
    Clin Cosmet Investig Dermatol; 2024; 17():1133-1144. PubMed ID: 38774812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highlights in pathogenesis of vitiligo.
    Mohammed GF; Gomaa AH; Al-Dhubaibi MS
    World J Clin Cases; 2015 Mar; 3(3):221-30. PubMed ID: 25789295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability in Vitiligo: Is there a Perfect Way to Predict it?
    Sahni K; Parsad D
    J Cutan Aesthet Surg; 2013 Apr; 6(2):75-82. PubMed ID: 24023428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmental Vitiligo.
    Sihag Y; Pathania YS
    J Cutan Med Surg; 2024 Aug; ():12034754241269186. PubMed ID: 39096150
    [No Abstract]   [Full Text] [Related]  

  • 13. New discoveries in the pathogenesis and classification of vitiligo.
    Rodrigues M; Ezzedine K; Hamzavi I; Pandya AG; Harris JE;
    J Am Acad Dermatol; 2017 Jul; 77(1):1-13. PubMed ID: 28619550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and emerging treatments for vitiligo.
    Rodrigues M; Ezzedine K; Hamzavi I; Pandya AG; Harris JE;
    J Am Acad Dermatol; 2017 Jul; 77(1):17-29. PubMed ID: 28619557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitiligo: Mechanistic insights lead to novel treatments.
    Frisoli ML; Harris JE
    J Allergy Clin Immunol; 2017 Sep; 140(3):654-662. PubMed ID: 28778794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of disease activity in vitiligo: A systematic review.
    Speeckaert R; Speeckaert M; De Schepper S; van Geel N
    Autoimmun Rev; 2017 Sep; 16(9):937-945. PubMed ID: 28698094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic management of vitiligo.
    Bleuel R; Eberlein B
    J Dtsch Dermatol Ges; 2018 Nov; 16(11):1309-1313. PubMed ID: 30335222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Aspects of Vitiligo Treatments.
    Bishnoi A; Parsad D
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic treatment of vitiligo : Balance and current developments].
    Meurer M; Ceric-Dehdari P
    Hautarzt; 2017 Nov; 68(11):876-884. PubMed ID: 29030646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.